Lantheus Holdings (LNTH) Tax Provisions (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Tax Provisions came in at $38.0 million in Q1 2026, up 61.08% year-on-year from $23.6 million in Q1 2025, and up 158.19% on a QoQ basis from -$65.3 million in Q4 2025.
Lantheus Holdings (LNTH) Tax Provisions (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has 13 years of Tax Provisions data on file, last reported at $38.0 million in Q1 2026.
- On a quarterly basis, Tax Provisions rose 61.08% year-over-year to $38.0 million in Q1 2026; TTM through Mar 2026 was $13.1 million, a 156.17% increase from a year earlier, with the FY2025 full-year figure at -$1.3 million, down 106.09% from the prior year.
- Tax Provisions for Q1 2026 stood at $38.0 million, up from -$65.3 million in the prior quarter.
- Over the last five years, Tax Provisions for LNTH reached as high as $45.0 million in Q3 2024 and fell as low as -$85.8 million in Q4 2024.
- Historically, Tax Provisions has averaged $8.4 million across 5 years, with a median of $22.3 million in 2024.
- On a YoY basis, Tax Provisions climbed as much as 1110.48% in 2022 and fell as far as 7104.29% in 2022.
- Year by year, Tax Provisions stood at -$57.1 million in 2022, then soared by 164.91% to $37.0 million in 2023, then tumbled by 331.66% to -$85.8 million in 2024, then gained by 23.92% to -$65.3 million in 2025, then soared by 158.19% to $38.0 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were $38.0 million in Q1 2026, -$65.3 million in Q4 2025, and $14.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Lantheus Holdings | 6.72 Bn | 6.22 Bn | 230.92 Mn | 37.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.99 Mn |
| Dec 31, 2025 | -65.28 Mn |
| Sep 30, 2025 | 14.61 Mn |
| Jun 30, 2025 | 25.76 Mn |
| Mar 31, 2025 | 23.58 Mn |
| Dec 31, 2024 | -85.80 Mn |
| Sep 30, 2024 | 45.03 Mn |
| Jun 30, 2024 | 22.30 Mn |
| Mar 31, 2024 | 40.20 Mn |
| Dec 31, 2023 | 37.04 Mn |
| Sep 30, 2023 | 28.00 Mn |
| Jun 30, 2023 | 29.56 Mn |
| Mar 31, 2023 | -8.30 Mn |
| Dec 31, 2022 | -57.06 Mn |
| Sep 30, 2022 | 21.78 Mn |
| Jun 30, 2022 | 18.99 Mn |
| Mar 31, 2022 | 14.94 Mn |
| Dec 31, 2021 | -792,000.00 |
| Sep 30, 2021 | -6.42 Mn |
| Jun 30, 2021 | -1.88 Mn |